BIIB-110

N/A

Report date: 2024/03/26 14:49:56

Base Information

Drug NameBIIB-110
Drug Alias NameALG-801BIIB-110BIIB110
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionActivin receptor type-2B inhibitors
TargetsActivin receptor type-2B
Therapy Area/IndicationsMuscular Atrophy, SpinalMuscular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlivegen USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlivegen USA Inc
Inactive CompaniesBiogen Inc
Active IndicationsMuscular Diseases
Inactive IndicationsMuscular Atrophy, Spinal

Other Information

ATC CodeN/A
Related LinksN/A